Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

Bioinformatics Market Potential

Vaccine Research & Development 2009

Veterinary Diagnostics Markets

Practical Guide to Finding Partners in Pharma & Biotech, 2nd edition

New Products

Advanced Wound Management Pipeline Technology and Market Forecasts to 2015

Artificial Disc Replacement Pipeline Technology and Market Forecasts to 2015

Brazil Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015

Brazil Orthopedic Devices Market Analysis and Forecasts to 2015

Canada Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015

Canada Diabetes Care Devices Market Analysis and Forecasts to 2015

Canada Medical Equipment Market Analysis and Forecasts to 2015

Cardiac Assist Devices Pipeline Technology and Market Forecasts to 2015

China Medical Equipment Market Analysis and Forecasts to 2015

Chronic Diseases on the Rise: Personal Health Systems to Play a Key Role in Disease Management

BioPortfolio | CuttingEdgeInfo Reports | Key Opinion Leaders

Relationship Management and Segmentation Data (PH122)

Key Opinion Leaders Relationship Management and Segmentation Data (PH122)

Increase thought leader participation and solidify opinion leader efforts

Key Opinion Leaders: Relationship Management and Segmentation Data is an essential tool for thought leader management professionals. This report is a definitive guide for engaging thought leaders in today's increasingly transparent environment. It shows teams how to be proactive and forward-thinking even while feeling the weight of ongoing regulatory pressure. By following this path, beyond building opinion leader relationships, your company will also create a lasting culture of integrity.

In response to challenges facing thought leader development teams, Key Opinion Leaders: Relationship Management and Segmentation Data provides actionable strategies that will deliver immediate impact. The report's detailed benchmarks enable you to compare your efforts against competitors. Interviews with top executives reveal fresh perspectives and solutions to persistent challenges and pitfalls. With this study - CEI's third annual thought leader management report - our analysts have honed their expertise to provide hard-hitting, easy-to-implement strategic recommendations.

The report focuses on these main areas:

Trends

Gain insight into the impact of the latest regulatory guidelines and learn how to increase MSLs' effectiveness in managing KOL relationships

Tools for Thought Leader Management Success

Learn the most common segmentation criteria that companies use to identify KOLs. Also, study the breakdown of company targets to better focus activities. Lastly, build an airtight documentation process while archiving thought leader history and measure activities to ensure that you reach your goals.

Thought Leader Management Structure and Staffing

Organize your thought leader development department to generate the most productive impact. Company structure and reporting relationships impact compliance. Survey data also show how surveyed companies support their thought leader development through staff supports and budgets.

Segmentation Data

The amount of segmentation data that Cutting Edge Information collected warrants its own section. Segmentation data are compiled from more than 85 survey respondents. The information is broken down by company category, individual therapeutic area and provider category. Use the data as a guideline for identifying and segmenting thought leaders to find the best opinion leader for the task at hand.

Companies Included in Report

More than 85 companies' fair-market value benchmarks.

The surveyed companies provided primary information either in the form of survey data or a telephone interview. Cutting Edge Information's analysts use secondary data to supplement the information provided by study participants. Surveyed companies include five top-20 and eight top-40 pharmaceutical companies, as well as biotechnology companies, medical device firms and third-party providers.

Therapeutic Areas Included in Report

* Autoimmune

* Cardiology and Thrombosis

* Central Nervous System (CNS)/Psychology

* Consumer Products

* Dermatology

* Diabetes (Type 1)

* Diabetes (Type 2)

* Gastroenterology

* Hematology

* Infectious Diseases

* Inflammation

* Lifestyle Medications

* Medical Devices

* Musculoskeletal

* Oncology

* Radiology

* Respiratory

* Urology

* Virology

* Women's Health

Published 2009

180 Pages

1000+ Metrics

85+ Companies

20 Therapeutic Areas
Table of Contents
Price: $7,695.00 / €5,143.34

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions